SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJudges Scientific Regulatory News (JDG)

Share Price Information for Judges Scientific (JDG)

Share Price is delayed by 15 minutes
Get Live Data
4,490.00    40.00 (0.90%)
Bid:
4,400.00
Ask:
4,580.00
Spread: 180.00 (4.091%)
Market Cap: £299.07m
JDG Live PriceLast checked at - London Stock Exchange

Intraday Judges Scientific Share Chart

Director/PDMR Shareholding

30 Jul 2025 07:00

RNS Number : 0866T
Judges Scientific PLC
30 July 2025
Β 

Judges Scientific plc

Director/PDMR Shareholding

Judges Scientific plc (AIM: JDG), a group focused on acquiring and developing companies in the scientific instrument sector announces that David Cicurel, Chief Executive Officer, and his spouse on 29 July 2025 effected a "Bed and ISA" by way of:

1. the sale of 310 ordinary shares of 5p each in the Company ("Ordinary Shares") by David Cicurel and immediate repurchase of the same number of Ordinary Shares, each at a price of 6425 pence per share, into David's ISA, and;

Β 

2. the sale of 315 Ordinary Shares by David Cicurel's spouse at a price of 6400 pence per share and immediate repurchase of the same number of Ordinary Shares at a price of 6410 pence per share, into her ISA.

Following this transaction David Cicurel's total beneficial and non-beneficial interest in Ordinary Shares remains unchanged. He is beneficially interested in 544,369 Ordinary Shares and beneficially and non beneficially interested inΒ 611,369Β Ordinary Shares, his non beneficial interest comprising 67,000 Ordinary Shares he has gifted to Shoftim Charitable Trust.

1

Β 

Details of the person discharging managerial responsibilities / person closely associated

Β 

a)

Β 

Name

Β 

Β 

David Cicurel

2

Β 

Reason for the notification

Β 

a)

Β 

Position/status

Β 

Β 

Chief Executive Officer

b)

Β 

Initial notification /Amendment

Β 

Β 

Initial notification

3

Β 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Β 

a)

Β 

Name

Β 

Β 

Judges Scientific plc

b)

Β 

LEI

Β 

Β 

2138004EXWWPTW1JOL31

4

Β 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Β 

a)

Β 

Description of the financial instrument, type of instrument

Β 

Identification code

Β 

Ordinary Shares in Judges Scientific plc

Β 

Β 

GB0032398678

Β 

b)

Β 

Nature of the transaction

Β 

Β 

Sale and repurchase of Ordinary Shares through a "Bed and ISA" arrangement

c)

Β 

Price(s) and volume(s)

Β 

Β 

Β 

Type

Price(s)

Β 

Volume(s)

Sale

6425p

Β 

310

Β 

Purchase

6425p

Β 

310

Β 

Β 

Β 

d)

Β 

Aggregated information

Β 

- Aggregated volume

Β 

- Price

Β 

Type

Price(s)

Β 

Volume(s)

Sale & repurchase

6425p

Β 

310

Β 

Β 

Β 

e)

Β 

Date of the transaction

Β 

Β 

29/07/25

f)

Β 

Place of the transaction

Β 

Β 

London Stock Exchange (XLON)

Β 

1

Β 

Details of the person discharging managerial responsibilities / person closely associated

Β 

a)

Β 

Name

Β 

Β 

Alejandra Cicurel

2

Β 

Reason for the notification

Β 

a)

Β 

Position/status

Β 

Β 

Person Closely Associated with David Cicurel, Chief Executive Officer

b)

Β 

Initial notification /Amendment

Β 

Β 

Initial notification

3

Β 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Β 

a)

Β 

Name

Β 

Β 

Judges Scientific plc

b)

Β 

LEI

Β 

Β 

2138004EXWWPTW1JOL31

4

Β 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Β 

a)

Β 

Description of the financial instrument, type of instrument

Β 

Identification code

Β 

Ordinary Shares in Judges Scientific plc

Β 

Β 

GB0032398678

Β 

b)

Β 

Nature of the transaction

Β 

Β 

Sale and repurchase of Ordinary Shares through a "Bed and ISA" arrangement

c)

Β 

Price(s) and volume(s)

Β 

Β 

Β 

Type

Price(s)

Β 

Volume(s)

Sale

6400p

Β 

315

Β 

Purchase

6410p

Β 

315

Β 

Β 

Β 

d)

Β 

Aggregated information

Β 

- Aggregated volume

Β 

- Price

Β 

Type

Price(s)

Β 

Volume(s)

Sale

6400p

Β 

315

Β 

Purchase

6410p

Β 

315

Β 

Β 

Β 

e)

Β 

Date of the transaction

Β 

Β 

29/07/25

f)

Β 

Place of the transaction

Β 

Β 

London Stock Exchange (XLON)

Β 

- Ends - Β 

Β For further information please contact:

Β 

Β 

Β 

Judges Scientific plc

David Cicurel, CEO

Brad Ormsby, CFO

Tel: +44 (0)Β 20 3829 6970

Β 

Β 

Shore Capital (Nominated Adviser & Joint Broker)

Stephane Auton

Harry Davies-Ball

Tel: +44 (0) 20 7408 4090

Β 

Liberum (Joint Broker)

Edward Mansfield

Nikhil Varghese

Josh Borlant

TelΒ : +44 (0) 20 3100 2222

Β 

Β 

Investec Bank plcΒ (Joint Broker)

Virginia Bull

Carlton Nelson

Tel: +44 (0) 207 597 4000

Alma PR (Financial Public Relations)

Sam Modlin

Joe Pederzolli

Rebecca Sanders-Hewett

Sarah Peters

Tel: +44 (0) 20 3405 0205

judges@almapr.co.uk

Β 

Notes to editors:

Judges Scientific plc (AIM: JDG), is a group focused on acquiring and developing companies in the scientific instrument sector. The Group now consists of 25 businesses acquired since 2005.

The acquired companies are primarily UK-based with products sold worldwide to a diverse range of markets including: higher education institutions, scientific research facilities, manufacturers and regulatory authorities. The UK is a recognised centre of excellence for scientific instruments. The Group has received five Queen's Awards for innovation and export.

The Group's companies predominantly operate in global niche markets, with long term growth fundamentals and resilient margins.

Judges ScientificΒ maintains a policy of selectively acquiring businesses that generate sustainable profits and cash. Shareholder returns are created through the reduction of debt, organic growth and dividends.

For further information, please visitΒ www.judges.uk.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
DSHDBGDRDXDDGUC
Date   Source Headline
11th Jun 20264:34 pmRNSDirector/PDMR Shareholding
1st Jun 20262:24 pmRNSTotal Voting Rights
26th May 20265:18 pmRNSPurchase of Ordinary Shares
20th May 20262:52 pmRNSResult of AGM
11th May 20263:10 pmRNSDirector/PDMR Shareholding
8th May 20265:05 pmRNSDirector/PDMR Shareholding
28th Apr 20267:00 amRNSNotice of AGM
22nd Apr 202611:53 amRNSConfirmation of Full Year Results
9th Apr 202611:14 amRNSDirector/PDMR Shareholding
2nd Apr 20267:00 amRNSDirector/PDMR Shareholding
31st Mar 20267:00 amRNSUnaudited Preliminary Results
25th Mar 20267:00 amRNSNotice of Investor Presentation
10th Mar 20267:00 amRNSDirector/PDMR Shareholding
9th Feb 20261:49 pmRNSDirector/PDMR Shareholding
2nd Feb 20269:38 amRNSTotal Voting Rights
29th Jan 20263:31 pmRNSDirector/PDMR Shareholding
29th Jan 20267:00 amRNSGrant of Options
22nd Jan 20267:00 amRNSFull Year Trading Statement and Notice of Results
8th Jan 202611:18 amRNSDirector/PDMR Shareholding
22nd Dec 20257:00 amRNSBlocklisting Return
22nd Dec 20257:00 amRNSBlocklisting Return
9th Dec 202510:25 amRNSDirector/PDMR Shareholding
3rd Dec 20257:00 amRNSAcquisition of the minority shareholding in GdB
26th Nov 20257:00 amRNSBoard Succession
13th Nov 20255:05 pmRNSDirector/PDMR Shareholding
11th Nov 202512:08 pmRNSDirector/PDMR Shareholding
3rd Nov 20257:00 amRNSTotal Voting Rights
20th Oct 20257:00 amRNSDirector/PDMR Shareholding
8th Oct 202511:43 amRNSDirector/PDMR Shareholding
1st Oct 202512:22 pmRNSTotal Voting Rights
18th Sep 20257:00 amRNSInterim Results
9th Sep 202511:42 amRNSDirector/PDMR Shareholding
21st Aug 20257:00 amRNSNotice of Investor Presentation
6th Aug 20255:46 pmRNSDirector/PDMR Shareholding
1st Aug 20257:00 amRNSTotal Voting Rights
30th Jul 20257:00 amRNSDirector/PDMR Shareholding
25th Jul 202510:07 amRNSDirector/PDMR Shareholding
24th Jul 20254:06 pmRNSDirector/PDMR Shareholding
24th Jul 20257:00 amRNSHalf Year Trading Update
8th Jul 20253:53 pmRNSDirector/PDMR Shareholding
1st Jul 20255:08 pmRNSTotal Voting Rights
1st Jul 20257:00 amRNSAppointment of Group Acquisitions Executive
23rd Jun 20257:00 amRNSBlocklisting Return
9th Jun 20251:37 pmRNSDirector/PDMR Shareholding
4th Jun 20255:03 pmRNSPurchase of Ordinary Shares
30th May 202512:06 pmRNSTotal Voting Rights
23rd May 202511:25 amRNSResult of AGM
13th May 20255:18 pmRNSPurchase of Ordinary Shares
8th May 20255:27 pmRNSDirector/PDMR Shareholding
28th Apr 20257:00 amRNSNotice of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.